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Abstract
Background: Several effects of leptin in the immune system rely on its capacity to modulate cytokine expression and
apoptosis in the thymus. Surprisingly, some of these effects are dependent on signal transduction through the IRS1/PI3-
kinase, but not on the activation of JAK2. Since all the well known effects of leptin in different cell types and tissues seem to
be dependent on JAK2 activation, we hypothesized that, at least for the control of thymic function, another, unknown
kinase could mediate the transduction of the leptin signal from the ObR towards the IRS1/PI3-kinase signaling cascade.
Methodology/Principal Findings: Here, by employing immunoblot, real-time PCR and flow citometry we show that the
tyrosine kinase, Fyn, is constitutively associated with the ObR in thymic cells. Following a leptin stimulus, Fyn undergoes an
activating tyrosine phosphorylation and a transient association with IRS1. All these effects are independent of JAK2
activation and, upon Fyn inhibition, the signal transduction towards IRS1/PI3-kinase is abolished. In addition, the inhibition
of Fyn significantly modifies the effects of leptin on thymic cytokine expression.
Conclusion/Significance: Therefore, in the thymus, Fyn acts as a tyrosine kinase that transduces the leptin signal
independently of JAK2 activation, and mediates some of the immunomodulatory effects of leptin in this tissue.
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Introduction
Both sides of extreme nutritional dysfunction, i.e., malnutrition
and obesity, are known to predispose to anomalous immune
activities, which include immunodeficiency, increased predisposi-
tion to inflammatory and autoimmune diseases and development
of certain types of cancer [1–4]. During the last ten years, a
number of studies have provided strong evidence to support a role
for leptin as a link between the metabolic and immune systems
[5,6]. Leptin was first characterized as a hormone responsible for
providing adipostatic signals to the hypothalamus, therefore
warranting the homeostatic control of body energy stores [7].
Later, an immunomodulatory role for leptin was described [8]
which explained, at least in part, the defective regulation of
immune response in mice [9] and humans [10] with leptin or
leptin-receptor deficiency.
The mechanisms involved in leptin-dependent regulation of
immune function include the capacity of leptin to inhibit thymic
apoptosis and the modulation of thymic cytokine expression
[5,11,12]. In young rodents, leptin can reduce up to 30% of basal
thymic apoptosis [11]. This effect is dependent on the expression
of the long form of the ObR, but not on the activation of the
receptor-associated tyrosine kinase JAK2 [11]. Interestingly, upon
inhibition of the docking protein, IRS1, or the enzyme, PI3-kinase,
most of the apoptosis-inhibiting effect of leptin is suppressed [11].
Since the ObR, as a member of the class 1 cytokine receptor
family, is devoid of intrinsic tyrosine kinase activity, we suspected
that an as yet unknown tyrosine kinase is activated in the response
to leptin, mediating the transduction of the signal from the ObR to
the IRS1/PI3-kinase/Akt pathway, and therefore modulating
thymic function.
Here, we show that the tyrosine kinase Fyn, associates with the
ObR and delivers a leptin-dependent immunomodulatory signal
in the thymus of rodents.
Materials and Methods
Materials and Chemicals
Antibodies against JAK-2 (sc-278), Fyn (sc-16), Lck (sc-13), Src
(sc-180, pJAK-2 (sc-16566), pSTAT3 (sc-7993), SHP2 (sc-424),
phosphotyrosine (sc-508), IRS-1 (sc-559), ObR (sc-8325), pERK
(sc-7383), Bcl-2 (sc-492), Bax (sc-493), rabbit IgG-B (sc-2040),
mouse IgG-B (sc-2039) and goat IgG-B (sc-2042) were from Santa
Cruz Biotechnology (Santa Cruz, CA, USA). Antibodies against
p-Src family Tyr416 (2101L) and p-Src family Tyr 527 (2105L)
were from Cell Signaling Technology (Danvers, MA, USA).
Protein A Agarose and nitrocellulose paper (Hybond ECL,
0.45 mm) were from Amersham (Bucks, UK). Leptin, JAK
inhibitor AG490 (tyrphostin B42) and Fyn inhibitor PP2 were
from Calbiochem (La Jolla, CA, USA). Tris base, phenylmethyl-
sulphonylfluoride, aprotinin, dithiothreitol, Triton X-100, Tween-
20, glycerol, bovine serum albumin (BSA, fraction V), lipopoly-
saccharide from Escherichia coli (LPS) and propidium iodide (PI)
were obtained from Sigma (St. Louis, MO, USA). SuperSignal
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tific (Rockford, IL, USA). Ficoll-Paque
TM PLUS was obtained
from Becton Dickinson Biosciences (San Jose, CA, USA), RPMI
1640 from Cultlab (Campinas, Brazil), and annexin V was
purchased from the Laboratory of Immunobiology of the
University of Sa ˜o Paulo (Sa ˜o Paulo, Brazil). Chemicals for real-
time PCR were from Invitrogen (Carlsbad, CA, USA) and Applied
Biosystems (Foster City, CA, USA). All other chemicals were
standard commercial products of reagent-grade quality. Antisense
(59 - CAC AGC CCA TTA TCC A - 39) (FynAS) and scramble
control (59 - CAT CCAGTC ACT ACC A - 39) (FynSCR) oligo-
nucleotides specific for Fyn were produced by IDT (San Diego,
CA, USA). The oligonucleotide sequences were submitted to
BLAST analyses (www.ncbi.nlm.nih.gov) and matched only for
the Rattus norvegicus Fyn coding sequence (NCBI/NM 012755).
Four peptides (1- M K K L F W D D V P N P K N; 2- P L L L E P
E P V S E E I S; 3- S Q P S V K Y A T L V S N V; 4- N H G E K
S V Y Y L G V S S) were constructed based on different portions
of the ObRb’s intracellular region, to be used in a competition
assay for the Fyn kinase against the receptor. These were
purchased from Peptide Protein Research Ltd (Wickham,
Hampshire, UK).
Experimental Animals
Three-weekold maleWistar rats and nine-week-old Lep/db(db/
db) and C57BLKS/J mice were obtained from the University of
Campinas Breeding Center. The Lep/db (db/db) mice were
originally purchased from the Jackson Laboratory (Bar Harbor,
Maine, USA) and are currently established as a colony at the
University of Campinas Breeding Center. Eight-month old Zucker
rats were obtained from the Laboratory of Physiology of the Federal
University of Sa ˜o Paulo (Brazil). The animals were allowed accessto
standard rodent chow and water ad libitum. All experiments
involving animals were in accordance with the guidelines of the
Brazilian College for Animal Experimentation (COBEA), and were
approved by the University of Campinas Ethical Committee. Room
temperature was maintained at 21–23uC with 12-h light/dark
cycles. The animals were age-matched for individual experiments
and randomly distributed into treatment or control groups with free
access to a standard rodent chow (Labina/Purina, Campinas, SP,
Brazil) and tap water. For some experiments, we additionally
employed 10 or 40 day-old male Wistar rats.
Experimental Protocols
For experiments of molecular associations and immunoblot-
tings, rats were treated with 100 mL of saline solution or with
100 mL of leptin 10
26M via the cava vein. The thymuses were
extracted after different time intervals: 0, 5, 10, 15, 20 and/or 30
min. For experiments of Fyn inhibition with antisense oligonucle-
otide (FynAS) (or the scrambled antisense FynSCR), rats were
treated with 400 mL of saline solution; 400 mL of leptin 10
26M;
400 mL of saline solution plus 2.0 nmol FynAS (or FynSCR), or
with 400 mL of leptin 10
26M plus 2.0 nmol FynAS (or FynSCR)
via intra-peritoneum (ip) during three consecutive days. For
experiments of Fyn inhibition with the chemical inhibitor (PP2),
rats were treated with 100 ml solution containing 2.5, 5 or 10 nM
of PP2 via ip 30 min before the thymus’ extraction. Five minutes
before the extraction, rats were also treated with 100 mL of saline
solution or with 100 mL of leptin 10
26M via the cava vein. For
experiments of molecular associations using db/db mice, the
animals were treated with 400 mL of saline solution or with 400 mL
of leptin 10
26M via ip and the thymus was extracted after 15
minutes. For experiments of molecular associations using Zucker
rats, the animals were treated with 100 mL of saline solution or
with 100 mL of leptin 10
25M via ip during three consecutive days.
The thymus was extracted on the following day. For the
determination of gene expression by Real Time PCR, rats were
treated with 100 mL of saline solution; 100 mL of lipopolysaccha-
ride (LPS) 1 mg/mL; 150 mL of PP2 5 nM; 100 mL of leptin
31.2 mM or with different combinations of these treatments.
Protocol for Immunoprecipitation and Immunoblotting
Rats or mice were anesthetized by ip injection of sodium
thiopental (50 mg/kg body weight), and the thymus or
hypothalamus were removed. The tissue was minced coarsely,
and homogenized immediately in extraction buffer at 4uC with a
Polytron PTA 20S generator (model PT 10/35, Brinkmann
Instruments, Inc., Westbury, NY, USA) operated at maximum
speed for 20 s. The extracts were centrifuged at 9,000 x g and 4uC
in a Beckman 70.1 Ti rotor (Palo Alto, CA, USA) for 20 min to
remove insoluble material, and the supernatants were used for
immunoprecipitation, for direct immunoblotting, as previously
described [13], or for a competition assay.
Protocol for Competition Assay
Samples containing 1.0mg total protein obtained from thymuses,
as described above, were incubated with different concentrations of
each one of the four peptides that were constructed to compete
against the ObRb receptor for association with Fyn. The
concentrations of the peptides employed were 0, 1, 10, 50 and
100 mg, and the incubations were performed overnight at 4uC
under gentle rocking. The samples were used for immunoprecip-
itation with anti-ObR and immunoblotting with anti-Fyn, anti-
JAK-2 or anti-SHP2.
Protocol for Thymocyte Isolation
Rat thymuses were gently homogenized in a manual Dounce
homogenizer. Thymocytes were overlaid onto a Ficoll-Paque
TM
PLUS layer, with density adjusted to 1.076 g/mL, and centrifuged
at 1,000 x g at room temperature for 25 min. The interface cell
layer containing thymocytes was recovered by Pasteur pipette,
washed twice in PBS, and centrifuged at 500 x g for 10 min
[14,15]. Cells were counted in a Neubauer chamber, and cell
viability was determined by the Trypan blue exclusion method.
Cells were only used when viability was greater than 98%.
Short-Term Cell Culture and Treatments
The in vitro thymocyte cultures were obtained by seeding
isolated thymus cells at a density of 10
5 or 10
6 cells/mL in RPMI
1640 in 1.5 cm
2 plate wells in a humidified atmosphere (5% CO2
at 37uC). For determination of markers of apoptosis and cytokine
expression, thymocytes were treated according to one of the
following protocols: control; leptin 10
28M; PP2 10
28M; or, leptin
10
28M + PP2 10
28M. Apoptosis was evaluated after 23 hours
using the Flow Cytometry method for all experiments.
Flow Cytometry
The samples were analyzed in a FACSCalibur flow cytometer
equipped with an argon laser and CellQuest software (Becton
Dickinson,SanJose,CA,USA).Tenthousand eventswereacquired
from each sample. The thymocyte populations were identified by
their light-scattering characteristics, enclosed in electronic gates,
and analyzed for the intensity of the fluorescent probe signal [15].
Analysis of Cell Viability by Annexin-V and PI Labelling
Thymocytes were labelled with annexin-V, following the manu-
facturer’s instructions [16]. Briefly, 10
5 or 10
6 cells were harvested
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binding buffer containing annexin V-FITC (1:500). After 20 min
of incubation at room temperature, thymocytes were centrifuged
at 1,000 x g for 5 min and resuspended in binding buffer
containing PI (1:50). Apoptosis was quantified by FACS analysis as
the number of annexin V-FITC positive and PI negative
thymocytes as a percentage of the total number, while necrosis
was quantified as the number of PI positive and annexin V-FITC
negative thymocytes as a percentage of the total number of cells.
Real-Time PCR
Thymic total RNA was extracted using Trizol reagent (Life
Technologies, Gaithersburg, MD, USA), according to the
manufacturer’s recommendations. Real-time PCR analysis of
gene expression was carried out in an ABI Prism 7500 sequence
detection system (Applied Biosystems). The optimal concentration
of cDNA and primers, as well as the maximum efficiency of
amplification, were obtained through seven-point, 3-fold dilution
curve analysis for each gene. Each PCR reaction contained 75 ng
of reverse-transcribed cDNA. Primers were purchased from
Applied Biosystems and were: TNFa, Rn99999017; IL-1b,
Rn00580432; IL-6, Rn00561420; IL-10, Rn00563409; and
GAPD, #4352338E, for rat. The PCR conditions were 2 min at
50uC; 10 min at 95uC, followed by 40 cycles at 95uC for 15 sec
and 60uC for 60 sec. Real-time data were analyzed using the
engine provided by Applied Biosystems.
Statistical Analysis
All numerical results are expressed as the means 6 sem of the
indicated number of experiments. The results of blots are
presented as direct comparisons of bands in autoradiographs.
The results of cell viability, estimated by annexin-V and
propidium iodide staining, were analyzed by ANOVA and a
post-hoc Tukey test. Level of significance was set at p,0.05.
Results
Src Family Members Are Expressed in the Thymus and
Undergo Tyrosine Phosphorylation Following Leptin
Injection
Proteins of the Src familycan mediate someof the effects of leptin
in isolated and transfected cell systems [17]. To evaluate the
presence of proteins of the Src family in the intact thymus, we
performed regular immunoblots of total thymus protein extracts. As
depicted in Figure 1A, Src, Fyn and Lck are expressed at high levels
in the thymus. A time-course experiment was performed to
determine the capacity of leptin to induce tyrosine phosphorylation
of the Src family members in the thymus. Although all three
proteins underwent a significant increase in tyrosine phosphoryla-
tion, peaking around 10–15 min, the effect of leptin demonstrated a
significantly greater induction of Fyn tyrosine phosphorylation
(increase of 325637% for Src, 470641% for Fyn and 186628%
for Lck, p,0.05 for Fyn vs. Src and vs. Lck, n=5) (Fig. 1B). In
addition, leptin induced Fyn tyrosine phosphorylation in a dose-
dependent manner starting at the concentration of 10
210M (100 ml
leptin through the cava vein) and peaking at 10
26–10
28M.
Therefore, in the remaining experiments, we concentrated our
efforts on the characterization of leptin action through Fyn, only.
Associations of Fyn/ObR and Fyn/IRS1 Are Modulated by
Leptin
The highest expression of Fyn and ObR in the thymus of Wistar
rats occurred at 21 days, according to immunoblot analysis of
thymic protein extracts obtained from animals at 10, 21 and 40
days of life (Fig. 2A). Therefore, the remainder of experiments was
performed always with 21-day old rats. Leptin-induced tyrosine
phosphorylation of Fyn peaked at 10 min (as shown in Fig. 1B),
which is similar to the timing of activation of other early leptin-
responsive proteins such as JAK2 and IRS1, and precedes some of
the late leptin-responsive proteins, such as STAT3 and ERK
(Fig. 2B). To start testing the hypothesis that Fyn can mediate
some of leptin’s actions in the thymus through IRS1, but
independently of JAK2, we performed immunoprecipitation
assays to evaluate the associations of Fyn with the ObR and
IRS1. As depicted in Figure 2C, Fyn is constitutively associated
with both ObR and IRS1. However, following leptin injection,
there is a time-dependent increase in the association of Fyn with
both ObR and IRS1. Fyn/ObR association was maximal at 5
Figure1. ExpressionofSrc family members in the thymus. (A) The
thymus from 21-d rats was homogenized and samples containing 0.2 mg
total protein were separated by SDS-PAGE, transferred to nitrocellulose
membranes and blotted with anti-Scr, Fyn or Lck antibodies; the specific
bands are indicated by arrows. (B) Rats were anesthetized and a single
injection of leptin (100 mL, 10
26M) was performed through the cava vein;
thymuses were obtained after the times depicted in the figure and
homogenized; samples containing 0.5 mg total protein were used in
immunoprecipitation assays with anti-Src, Fyn or Lck antibodies;
immunocomplexes were separated by SDS-PAGE, transferred to nitrocel-
lulose membranes and blotted with anti-phosphotyrosine antibodies. (C)
Rats were anesthetized and a single injection of leptin (100 mL,
concentrations ranging from 10
212 to 10
24M) was performed through
the cava vein; thymuses were obtained after 10 min and homogenized;
samples containing 0.5 mg total protein were used in immunoprecipita-
tion assays with anti-Fyn antibodies; immunocomplexes were separated
by SDS-PAGE, transferred to nitrocellulose membranes and blotted with
anti-phosphotyrosine antibodies. The depicted blots are representative of
n=5. MW, molecular mass; Thy, thymus.
doi:10.1371/journal.pone.0007707.g001
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The capacity of leptin to induce Fyn activation was further
demonstrated by the time-course of Fyn tyrosine phosphorylation
at residue 416, which is an activating phosphorylation site, and
527, which is an inactivating phosphorylation site. As depicted in
Figure 2D, leptin-induced Fyn-Tyr416 phosphorylation peaked at
5 min and had almost vanished at 20 min, this was followed by
Fyn-Tyr527 phosphorylation peaking at 20 min. Interestingly,
Fyn-Tyr527 phosphorylation was present in the basal state, when
Fyn is inactive, undergoing a considerable reduction of phosphor-
ylation at 5 and 10 min (Fig. 2D). Furthermore, it is important to
notice that the highest Fyn/ObR association coincides with the
peak of leptin-induced Fyn-Tyr416 phosphorylation (at 5 min)
and, using the anti-Fyn-Tyr416 specific antibody, the Fyn-ObR
complex could be detected at its highest level at 5 min (Fig. 2E).
Conversely, ObR co-immunoprecipitates with Fyn-Tyr527 before
leptin treatment or at 20 min after leptin injection (Fig. 2E).
Fyn Associates with the ObR in the Box1/Box2 Transition
Domain
Four peptides were designed to be used in binding-competition
assays with the objective of defining the site of Fyn interaction with
the ObR (Fig. 3A). As depicted in Figure 3B, only peptide 2 was
capable, in a dose-dependent manner, of disrupting the Fyn/ObR
complex. Peptide 1 efficiently competed with the JAK2 binding
site, while peptide 3 efficiently competed with the SHP2 binding
site (Fig. 3C). Interestingly, in db/db mice, which lack most of the
box 2 domain of the ObR, Fyn was still capable of binding to the
ObR, although in a lower amount than in control mice (Fig. 3D).
In Zucker rats, which lack an extracelluar portion of the ObR, Fyn
was also bound to the receptor (Fig. 3E). Nevertheless, in both
animal models harboring defective ObRs, the ability of leptin to
promote Fyn tyrosine phosphorylation was virtually absent
(Figs. 3D and 3E).
Fyn Expression/Activity Is Inhibited by Two Distinct
Methods
To provide the adequate tools to determine the role of Fyn in
leptin’s action in the thymus, two methods were employed. Firstly,
Fyn expression was reduced by treating living rats with a
phosphorthioate modified antisense oligonucleotide, which pro-
vided a significant reduction of Fyn expression in doses of 2.0 and
4.0 nmol (reductions of 5867% and 6665%, p,0.05 vs. control,
respectively) (Fig. 4A). Secondly, leptin-induced activation of Fyn
was inhibited with the specific inhibitor PP2, which completely
abrogated leptin-induced tyrosine phosphorylation of Fyn, but
produced no changes in leptin-induced activation of JAK2 and
ERK (Fig. 4B).
Fyn Is Not Involved in Leptin-Dependent Control of
Apoptosis in the Thymus
Leptin exerts a potent anti-apoptotic effect on thymic cells [11].
To evaluate whether the inhibition of Fyn would result in the
modulation of the anti-apoptotic activity of leptin, rats were
treated with the anti-Fyn antisense oligonucleotide or with PP2
and then treated with leptin. As depicted in Figure 5A, the
inhibition of Fyn resulted in no modification of the leptin-
dependent reduction in the expression of the pro-apoptotic
Figure 2. Fyn activation in the thymus. (A) Thymuses from 10-, 21-, or 40-d rats were homogenized and samples containing 0.2 mg total protein
were separated by SDS-PAGE, transferred to nitrocellulose membranes and blotted with anti-Fyn or ObR antibodies; the specific bands are indicated
by the arrows. (B) Rats were anesthetized and a single injection of leptin (100 mL, 10
26M) was given through the cava vein; thymuses were obtained
after the times depicted in the figure and homogenized; samples containing 0.5 mg total protein were used in immunoprecipitation assays with anti-
JAK2, IRS1 or STAT3 antibodies; immunocomplexes were separated by SDS-PAGE, transferred to nitrocellulose membranes and blotted with anti-
phosphotyrosine antibodies; samples containing 0.2 mg total protein were separated by SDS-PAGE, transferred to nitrocellulose membranes and
blotted with anti-phospho ERK antibodies. (C–E) Rats were anesthetized and a single injection of leptin (100 mL, 10
26M) was given through the cava
vein; thymuses were obtained after the times depicted in the figure and homogenized; in C and E, samples containing 0.5 mg total protein were used
in immunoprecipitation (IP) assays with anti-Fyn (C), or phospho-(
416Tyr)Fyn (E), or phospho-(
527Tyr)Fyn (E) antibodies; immunocomplexes were
separated by SDS-PAGE, transferred to nitrocellulose membranes and blotted (IB) with anti-ObR or IRS1 antibodies (C), or anti-ObR (E); in D, samples
containing 0.2 mg total protein were separated by SDS-PAGE, transferred to nitrocellulose membranes and blotted with anti-phospho-(
416Tyr)Fyn, or
phospho-(
527Tyr)Fyn. The depicted blots are representative of n=5. MW, molecular mass.
doi:10.1371/journal.pone.0007707.g002
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of the anti-apoptotic protein, Bcl-2. In addition, the inhibition of
Fyn with PP2 had no impact on leptin-induced inhibition of
apoptosis of isolated thymocytes (Fig. 5B).
Fyn Mediates the Effects of Leptin on Thymic Cytokine
Expression
Leptin is known to modulate cytokine expression in the thymus
[5]. To test the hypothesis that Fyn could mediate some of the
leptin’s effects on the control of cytokine expression, rats were pre-
treated with PP2 and the effect of leptin on basal and LPS-
stimulated cytokine expressions were determined by real-time
PCR. As depicted in Figures 5C and 5D, the inhibition of Fyn
resulted in significant reductions of basal and LPS-stimulated
leptin-dependent IL-1b and TNF-a expressions by thymic cells.
Fyn Undergoes Leptin-Induced Tyrosine Phosphorylation
in the Hypothalamus
Due to the classical hypothalamic actions of leptin in the control
of food intake [7], we evaluated whether Fyn is expressed in the
hypothalamus of rats and if it becomes tyrosine phosphorylated
following an acute dose of leptin. As shown in Figure 6A, both Fyn
and JAK2 are expressed in the hypothalamus and undergo rapid
tyrosine phosphorylation following leptin injection. In addition,
upon the inhibition of Fyn activity, a reduction in leptin-induced
Figure 3. Exploring the Fyn/ObR association. (A) Four different peptides, corresponding to the protein sequence of the regions of the ObR, as
depicted, were synthesized to compete with the receptor for Fyn binding; the binding sites for JAK2, SHP2 and STAT3 are depicted. (B–C) Thymus
total protein homogenate samples containing 1.0 mg protein were incubated with peptides 1–4 at concentrations ranging from 0–100 mg, as
depicted; immunoprecipitation (IP) assays were performed with the anti-ObR antibody; immunocomplexes were separated by SDS-PAGE, transferred
to nitrocellulose membranes and blotted (IB) with the anti-Fyn (B) or the anti-JAK2 (C), or the anti-SHP2 (C) antibodies. (D–E) Lean (Db/Db) or obese
(db/db) mice (D), or lean Wistar (Wi) or obese Zucker (Zu) rats (E) were acutely treated with leptin (400 ml, 10
26M ip, for mice and 100 ml, 10
26M via
cava vein, for rats) (+) or an equal volume of saline (2) and the thymuses were obtained, homogenized and samples containing 0.5 mg protein were
used in immunoprecipitation assays with the anti-ObR antibody; immunocomplexes were separated by SDS-PAGE, transferred to nitrocellulose
membranes and blotted with anti-Fyn antibody; or, 0.2 mg protein was separated by SDS-PAGE, transferred to nitrocellulose membranes and blotted
with anti-phospho Fyn antibody. The depicted blots are representative of n=5.
doi:10.1371/journal.pone.0007707.g003
Figure 4. Inhibiting Fyn. (A) Rats were treated once a day for three
days with a single 400 ml ip dose of buffer containing 0–8 nmol Fyn
antisense (FynAS) or scrambled (FynSCR) phosphorthioate modified
oligonucleotides; at the end of the experimental period the thymuses
were obtained, homogenized and samples containing 0.2 mg total
protein were separated by SDS-PAGE, transferred to nitrocellulose
membranes and blotted with anti-Fyn or anti-IRS1 antibodies. (B) Rats
were pre-treated with a single dose of PP2 (5 nmol in 100 ml buffer, ip)
(+) or saline (2), 30 min prior to leptin treatment. A single dose of leptin
(100 ml1 0
26M, via cava vein) (+), or similar volume of saline (2) was
then injected; the thymuses were obtained for homogenization;
samples containing 0.5 mg total protein were used in immunoprecip-
itation assays with anti-Fyn or anti-JAK2 antibodies; immunocomplexes
were separated by SDS-PAGE, transferred to nitrocellulose membranes
and blotted (IB) with anti-phosphotyrosine antibody; or 0.2 mg protein
was separated by SDS-PAGE, transferred to nitrocellulose membranes
and blotted with anti-phospho ERK antibody. The depicted blots are
representative of n=5.
doi:10.1371/journal.pone.0007707.g004
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has no effect on JAK2 expression or leptin-induced JAK2
phosphorylation (Fig. 6B).
Discussion
The ObR belongs to the IL-6-like, class 1 cytokine receptor
family that contains an extracellular ligand-binding domain, a
transmembrane domain and an intracellular signaling domain
devoid of intrinsic catalytic activity [18,19]. Upon ligand binding,
the receptor undergoes a conformational change resulting in the
transphosphorylation and activation of a noncovalently bound
tyrosine kinase JAK2 [20], which catalyzes the phosphorylation of
other tyrosine residues on JAK2, ObR and additional proteins
involved in leptin signal transduction [21].
Most actions of leptin were studied in the hypothalamus where
this hormone/cytokine exerts potent anorexigenic/thermogenic
effects [7,22,23]. Signal transduction and functional studies in
neural tissue suggest that the activation of JAK2 is an obligatory
event linking the ObR to downstream effectors of leptin action
[19,22]. However, in the thymus, where leptin modulates
apoptosis and cytokine expression, JAK2 independent effects have
been described [11]. Since the functional characteristics of the
ObR relies on the recruitment of an independent tyrosine kinase
in order to appropriately deliver the incoming signals, we
hypothesized that, in the thymus, a tyrosine kinase other than
JAK2 would play a role in leptin activity.
A recent study has shown that, in an isolated cell system,
proteins of the Src family can be activated in response to leptin in a
JAK2-independent fashion [17]. In the first part of the study, we
showed that members of the Src family are highly expressed in the
thymus and respond to an acute dose of leptin by undergoing
tyrosine phosphorylation. Since the highest leptin-induced tyrosine
phosphorylation was observed in Fyn, and also, because Fyn has
been implicated as an important intermediate in a number of
immunological functions [24–27], we decided to concentrate our
efforts to explore the role of Fyn on leptin action in the thymus.
The dynamics of Fyn tyrosine phosphorylation, in response to
leptin, were similar in timing to the activation of JAK2, although
occurring faster than the engagement of the substrates of JAK2 and,
therefore, suggesting that fyn activation exists as a parallel and
independent phenomenon with regard to the classic JAK2 signaling
pathway [28,29]. Interestingly, the time-course and protein
association experiments showed that, under basal conditions, Fyn
is predominantly tyrosine phosphorylated on the inhibitory
527Tyr
residue and is constitutively associated at a low level with the ObR.
Upon leptin treatment, Fyn undergoes a transient increase in
association with the ObR, which coincides with the induction of
tyrosine phosphorylation at the activating
416Tyr residue. Finally,
the deactivating
527Tyr phosphorylation reinstalls and the levels of
Fyn bound to the ObR return to basal levels. While tyrosine
phosphorylated on the
416Tyr residue, and highly associated with
the ObR, Fyn associates with IRS1 establishing a protein complex
that may drive JAK2-independent signals.
Using a peptide competition assay we mapped the transition of
box1 to box 2 as the binding site for Fyn in the ObR. This site lies
justbelow the JAK2binding siteand isapproximately 70 residuesup
from the SHP2 binding site [22,30]. Using two natural mutants of
the ObR that retain the transition box1 to box2 region [31], in the
Figure 5. Effects of Fyn inhibition on apoptosis and cytokine
expression. (A) Rats were treated ip for three days with Fyn antisense
phosphothioate modified oligonucleotide (FynAS) (400 ml, 2 nmol). On
the fourth day, the rats were injected via intra cava vein either with
100 ml saline (C and FynAS) or with an equal volume of leptin (10
26M)
(Lep and FynAS+Lep); the thymuses were obtained, homogenized and
0.2 mg protein was separated by SDS-PAGE, transferred to nitrocellu-
lose membranes and blotted with anti-Bax or anti-Bcl-2 antibodies. (B)
Isolated thymocytes were treated with leptin (10
28M)(Lep) or PP2
(10
28M) or both together and apoptosis was determined by the
annexin method after 24h. (C–D) Rats were treated ip with a single dose
of 100 mL of saline solution (C); 100 mL of lipopolysaccharide (LPS)
1 mg/mL; 150 mL of PP2 5 nM; 100 mL of leptin 31.2 mM (Lep) or with
different combinations of these treatments; the sequence of treatment
was, PP2, followed by leptin after 30 min and LPS after 30 min. Thymus
was obtained after 2 h and RNA was prepared for determination of
IL-1b (C) and TNF-a expression by real-time PCR. In all experiments
n=5. *p,0.05 vs. C; #p,0.05 vs. lep; 1p,0.05 vs. Lep+LPS.
doi:10.1371/journal.pone.0007707.g005
Figure 6. Fyn expression and activation in the hypothalmus.
(A–B) Some rats were used without previous treatment (A), or some rats
were treated with Fyn inhitor PP2 (5 nmol in 100 ml buffer, ip) 30 min
before leptin injection (B). Anesthetized rats were injected via intra cava
vein either with 100 ml saline (C) or with an equal volume of leptin
(10
26M) (Lep and PP2+Lep); the hypothalami were obtained, homog-
enized and samples containing 0.5 mg total protein were used in
immunoprecipitation assays with anti-Fyn or anti-JAK2 antibodies;
immunocomplexes were separated by SDS-PAGE, transferred to
nitrocellulose membranes and blotted with anti-phosphotyrosine
antibody; or 0.2 mg protein was separated by SDS-PAGE, transferred
to nitrocellulose membranes and blotted with anti-Fyn or anti-JAK2
antibodies. The depicted blots are representative of n=5. In all
experiments, n=5; *p,0.05 vs. C.
doi:10.1371/journal.pone.0007707.g006
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of the receptor with Fyn, however most of the leptin-induced Fyn
tyrosine phosphorylation was lost in both cases. In fact, in db/db
mice, where the ObR lacks most of the box2 region, the basal
association of Fyn was considerably lower than in control mice.
In order to evaluate the role of Fyn in leptin actions in the
thymus we used two distinct methods to reduce Fyn activity, in vivo.
With the antisense oligonucleotide approach, we reduced Fyn
expression to approximately 40% of basal levels, while using the
chemical inhibitor PP2 we virtually abolished leptin-induced Fyn
activation. With these two methods we could then determine the
role of Fyn in two important phenomena modulated by leptin in
the thymus, apoptosis and cytokine expression [5,8,11].
The capacity of leptin to reduce the rate of apoptosis in the
thymus has been evaluated in several studies [5,11,32]. It is
believed that, by controlling the survival of certain lymphocyte
subpopulations, leptin may impact on the immune repertoire,
predisposing or restraining the development of certain diseases.
One such example is the apparent role played by leptin in the
development of autoimmunity [33]. In addition, a tight connection
between thymic function in malnutrition and leptin activity in this
tissue has been demonstrated, reinforcing the role for leptin in the
connection between metabolic and immune function [6,12,32].
When we evaluated the role of Fyn in leptin-inhibited apoptosis
in the thymus, we found no significant changes in the expression of
Bax and Bcl-2 and also in the number of apoptotic cells, as
determined by flow cytometry. These experiments were repeated a
number of times with variations in the doses and times of
treatment with the respective inhibitors of Fyn and, consistently,
we could detect no changes in the rate of apoptosis inhibited by
leptin. Therefore, we believe that Fyn plays no important role in
this process.
Regarding the effects of leptin in the modulation of cytokine
production, studies have shown that it can induce the expression of
inflammatory cytokines that play a role in the development of
autoimmune diseases [34]. Moreover, leptin deficient ob/ob mice
and humans lacking the functional ob gene are immunodeficient
and present a defective production of cytokines such as IL-2,
TNF-a, IFN-c and IL-1b [8,10,33]. Here, we observed that the
inhibition of Fyn activity resulted in reduced IL-1b and TNF-a
expression, in response to leptin, and also to the association of
leptin and LPS. Thus, we suspect that Fyn plays a more
immunomodulatory role in the action of leptin in the thymus
rather than in the control of cell survival. Finally, in the last part of
the study, we showed that Fyn is also expressed in the main site of
action of leptin, the hypothalamus, and responds to leptin by
undergoing a rapid tyrosine phosphorylation.
As a whole, this study identifies a novel tyrosine kinase that is
capable of associating and transducing the leptin signal, indepen-
dently of JAK2. This signaling pathway plays an immunomodu-
latory role in the thymus. As Fyn also responds to leptin in the
hypothalamus, efforts to define its role in the neural action of
leptin are required.
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